Skip to content

AMBITYON STUDY: the relation between inflammation cells, immune system cells and the development of arteriosclerosis: a study with MRI in young adults.

Atherosclerosis Monitoring and Biomarker measurements In the YOuNg

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25569
Enrollment
575
Registered
2013-09-09
Start date
2014-01-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis, MR Imaging, biomarkers, presence, progression, young adults

Interventions

Questionnaire: to obtain information regarding age, gender, race, medical history, medication use and lifestyle (smoking, alcohol consumption, dietary intake and social economic status), Physical exa

Sponsors

University Medical Center Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: no medical history of cardiovascular disease and no cardiovascular preventive medication; between 25-35 years of age; willing and be able to sign informed consent

Exclusion criteria

Exclusion criteria: subjects with claustrophobia; subjects with a history of allergic reactions to MR contrast fluids; subjects with implanted electronic devices (i.e. pacemaker, internal cardioverter-defibrillator, cochlear implants, nerve- and bone stimulators); subjects with ferromagnetic clips in brain, eyes or lungs; subjects with a known reduced kidney function (GFR< 60 ml/min) subjects who are pregnant

Design outcomes

Primary

MeasureTime frame
(a) presence and (b) rate of change in atherosclerosis over time in young adulthood (visualized with state-of the-art magnetic resonance imaging techniques) predicted by certain biomarkers of circulating cells and systemic inflammation

Secondary

MeasureTime frame
aortic wall thickness and volume; presence and number of aortic atherosclerotic plaques (luminal protrusion of > 1 mm in radial thickness); the extent of aortic atherosclerosis (expressed as % of affected aorta as fraction of total aorta depicted)

Contacts

Public ContactA.L.M. Eikendal

Department of Radiology University Medical Center Utrecht Room E.01.132 Heidelberglaan 100

a.l.m.eikendal@umcutrecht.nl+31(0)88 75 503 55 / +31(0)6 219 786 19

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)